デフォルト表紙
市場調査レポート
商品コード
1402015

ポリメラーゼ連鎖反応市場の2030年までの予測:製品別、用途別、エンドユーザー別、地域別の世界分析

Polymerase Chain Reaction Market Forecasts to 2030 - Global Analysis By Product, Application, End User and By Geography

出版日: | 発行: Stratistics Market Research Consulting | ページ情報: 英文 200+ Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
ポリメラーゼ連鎖反応市場の2030年までの予測:製品別、用途別、エンドユーザー別、地域別の世界分析
出版日: 2023年12月01日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Stratistics MRCによると、世界のポリメラーゼ連鎖反応市場は2023年に89億米ドルを占め、予測期間中にCAGR 11.5%で成長し、2030年には191億米ドルに達する見込みです。

ポリメラーゼ連鎖反応は、体外増幅によって特定のDNA鎖の数100万コピーを生産する分子的手法です。PCRは感度が高く、微量のDNAを検出することができます。これは、ある種の病気の初期段階や、法医学サンプル中の微量DNAを分析する場合など、標的DNAが低濃度で存在する応用において特に有利です。

インド医学研究評議会(ICMR)によると、インドでは2027年までにがん患者が12%増加します。

遺伝子検査需要の高まり

遺伝子検査に対する需要の高まりは、ポリメラーゼ連鎖反応市場の重要な促進要因となっています。遺伝子検査は、遺伝的変異、突然変異、遺伝子発現パターンを特定するために個人のDNAを分析することを含みます。PCRは、さらなる分析のために特定のDNA配列を増幅することによって、このプロセスで重要な役割を果たしています。さらに、遺伝子検査は、自分の祖先について興味を持ち、遺伝的遺産を探求したいと考える個人の間で人気を博しています。したがって、これらの進歩は遺伝子検査におけるPCRの応用を拡大し、PCR市場の成長に寄与しています。

高コスト

PCR装置、試薬、消耗品への初期投資は、熟練した人材の必要性と相まって、特に小規模の診断施設や研究所にとっては、全体的な費用の一因となっています。PCR装置の高度な性質と品質管理のための継続的な要件は、運用コストをさらに増加させる。さらに、PCR検査にかかる費用は患者や医療システムに負担をかける可能性があり、最先端の診断サービスの手頃な価格と公平な分配に影響を与えます。したがって、高コストは市場拡大の大きな障壁となっています。

技術の進歩

リアルタイムPCRは、PCR増幅をリアルタイムで検出し定量化することを可能にし、増幅プロセス中に即座に結果を提供します。このリアルタイムモニタリングにより、より迅速で正確な分析が可能となり、臨床診断、遺伝子検査、研究などの分野で重宝されています。さらに、PCR装置技術の進歩により、より使いやすく自動化されたシステムが開発されています。高度な温度制御アルゴリズムと直感的なソフトウェアインターフェースを備えた統合型サーマルサイクラーは、研究者、臨床医、技術者を含む幅広いユーザーにとってPCRをより身近なものにしました。このような技術の進歩は、市場の需要を加速する大きな要因となっています。

複雑さと専門技術

プライマー設計、反応条件の最適化、データ解析を含むPCR技術に関わる様々なステップには、一定レベルの技術的知識とトレーニングが必要です。PCRプロトコールは、目的のDNA領域を特異的に対象とするプライマーの慎重な設計と選択を必要とします。適切な融解温度を持つプライマーを設計し、二次構造を避け、プライマー-ダイマー相互作用を最小化することは難しい課題です。ポリメラーゼ連鎖反応の実行に必要な複雑さと技術的専門知識は、ポリメラーゼ連鎖反応市場の抑制要因として作用します。

COVID-19の影響

COVID-19パンデミックはポリメラーゼ連鎖反応市場の成長に大きな影響を与えました。臨床診断市場セグメントにおける需要の増加はPCR市場に好影響を与えました。医療専門家はCOVID-19の症状を示す人々に診断検査を行うよう助言し、ウイルス培養検査は当局によって推奨されていないため、これらの検査のほぼすべてがRT-PCRを使用しています。製薬会社やバイオテクノロジー企業の多くは、COVID-19治療のための新しい分子やリード化合物を特定するための研究開発部門に注力していました。

予測期間中、試薬セグメントが最大となる見込み

試薬セグメントが最大のシェアを占めると推定されています。PCR試薬には、DNAポリメラーゼ、プライマー、ヌクレオチド、バッファーを含むさまざまな化学物質が含まれ、それぞれが反応において特定の役割を果たします。TaqポリメラーゼのようなDNAポリメラーゼは相補的DNA鎖の合成を触媒し、プライマーはDNA増幅の出発点を提供します。ヌクレオチドは新たに合成されるDNA鎖の構成要素として機能し、緩衝液は酵素活性に最適なpH条件を維持します。PCR反応の正確性と効率性のためには、高品質で信頼性の高い試薬の需要が最も重要です。

予測期間中、診断センターセグメントが最も高いCAGRが見込まれる

診断センターセグメントは予測期間中に有利な成長を遂げると予測されています。PCR技術は、感染症、遺伝子疾患、がんを含む様々な疾患の検出のために診断センターで広く利用されています。診断センターはPCRの高い感度と特異性を利用して特定のDNAまたはRNA配列を同定し定量し、疾患の早期かつ正確な診断に役立てています。PCRの多用途性により、診断センターは幅広い検査を提供することができ、包括的な患者ケアに貢献します。

最大シェアの地域

推定期間中、北米が最大の市場シェアを占めました。疾患の頻度が高いこと、同地域に重要な参入企業が存在すること、有利な規制が存在すること、医療インフラの進歩に関連する政府のイニシアチブが多いことなどが、同地域市場の成長に寄与しています。さらに、診断を成功させるための最新製品が利用可能であることに対する患者の意識が高まっていることも、成長を後押しする要因となっています。

CAGRが最も高い地域:

アジア太平洋は、感染症罹患率の上昇、個別化医療に対する認識の高まり、医療制度の改善などにより、予測期間中に有益な成長を遂げることが期待されます。アジア諸国では、特にゲノム研究、腫瘍学、感染症研究の分野で研究活動が活発化しています。このため、DNAを増幅する正確で効率的な方法としてPCRが広く使用されるようになった。さらに、この地域の多様な人口と遺伝的変異は、個別化された治療戦略のための強固な分子診断を必要とし、PCR市場をさらに活性化させています。

無料カスタマイズサービス:

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます。

  • 企業プロファイル
    • 追加市場参入企業の包括的プロファイリング(3社まで)
    • 主要企業のSWOT分析(3社まで)
  • 地域セグメンテーション
    • 顧客の関心に応じた主要国の市場推定・予測・CAGR(注:フィージビリティチェックによる)
  • 競合ベンチマーキング
    • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

  • 概要
  • ステークホルダー
  • 調査範囲
  • 調査手法
    • データ鉱業
    • データ分析
    • データ検証
    • 調査アプローチ
  • 調査情報源
    • 1次調査情報源
    • 2次調査情報源
    • 前提条件

第3章 市場動向分析

  • イントロダクション
  • 促進要因
  • 抑制要因
  • 機会
  • 脅威
  • 製品分析
  • 用途分析
  • エンドユーザー分析
  • 新興市場
  • 新型コロナウイルス感染症(COVID-19)の影響

第4章 ポーターのファイブフォース分析

  • 供給企業の交渉力
  • 買い手の交渉力
  • 代替品の脅威
  • 新規参入業者の脅威
  • 競争企業間の敵対関係

第5章 世界のポリメラーゼ連鎖反応市場:製品別

  • イントロダクション
  • 装置
    • デジタルPCRシステム
    • 標準的なPCRシステム
    • リアルタイムPCRシステム
  • 試薬
  • 消耗品
  • その他の製品

第6章 世界のポリメラーゼ連鎖反応市場:用途別

  • イントロダクション
  • 腫瘍学
  • 血液検査
  • 病原体の検出
  • 研究
  • 法医学
  • その他の用途

第7章 世界のポリメラーゼ連鎖反応市場:エンドユーザー別

  • イントロダクション
  • 医薬品
  • 病院
  • 臨床研究機関
  • 診断センター
  • 学術界
  • 研究所
  • その他のエンドユーザー

第8章 世界のポリメラーゼ連鎖反応市場:地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • イタリア
    • フランス
    • スペイン
    • その他の欧州
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • ニュージーランド
    • 韓国
    • その他のアジア太平洋
  • 南米
    • アルゼンチン
    • ブラジル
    • チリ
    • その他の南米
  • 中東とアフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • カタール
    • 南アフリカ
    • その他の中東とアフリカ

第9章 主要発展

  • 契約、パートナーシップ、コラボレーション、合弁事業
  • 買収と合併
  • 新製品の発売
  • 事業拡大
  • その他の主要戦略

第10章 企業プロファイル

  • Danaher Corporation
  • Fluidigm Corporation
  • Agilent Technologies, Inc.
  • Stilla Technologies
  • Abbott
  • Cytiva
  • Microsynth AG
  • Qiagen
  • JN Medsys
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific, Inc.
  • F. Hoffmann-La Roche Ltd
  • Siemens
  • Johnson & Johnson Private Limited
  • Bruker
図表

List of Tables

  • Table 1 Global Polymerase Chain Reaction (PCR) Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Polymerase Chain Reaction (PCR) Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Polymerase Chain Reaction (PCR) Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 4 Global Polymerase Chain Reaction (PCR) Market Outlook, By Digital PCR Systems (2021-2030) ($MN)
  • Table 5 Global Polymerase Chain Reaction (PCR) Market Outlook, By Standard PCR Systems (2021-2030) ($MN)
  • Table 6 Global Polymerase Chain Reaction (PCR) Market Outlook, By Real-Time PCR Systems (2021-2030) ($MN)
  • Table 7 Global Polymerase Chain Reaction (PCR) Market Outlook, By Reagents (2021-2030) ($MN)
  • Table 8 Global Polymerase Chain Reaction (PCR) Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 9 Global Polymerase Chain Reaction (PCR) Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 10 Global Polymerase Chain Reaction (PCR) Market Outlook, By Application (2021-2030) ($MN)
  • Table 11 Global Polymerase Chain Reaction (PCR) Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 12 Global Polymerase Chain Reaction (PCR) Market Outlook, By Blood Testing (2021-2030) ($MN)
  • Table 13 Global Polymerase Chain Reaction (PCR) Market Outlook, By Pathogen Detection (2021-2030) ($MN)
  • Table 14 Global Polymerase Chain Reaction (PCR) Market Outlook, By Research (2021-2030) ($MN)
  • Table 15 Global Polymerase Chain Reaction (PCR) Market Outlook, By Forensic (2021-2030) ($MN)
  • Table 16 Global Polymerase Chain Reaction (PCR) Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 17 Global Polymerase Chain Reaction (PCR) Market Outlook, By End User (2021-2030) ($MN)
  • Table 18 Global Polymerase Chain Reaction (PCR) Market Outlook, By Pharmaceutical (2021-2030) ($MN)
  • Table 19 Global Polymerase Chain Reaction (PCR) Market Outlook, By Hospital (2021-2030) ($MN)
  • Table 20 Global Polymerase Chain Reaction (PCR) Market Outlook, By Clinical Research Organizations (2021-2030) ($MN)
  • Table 21 Global Polymerase Chain Reaction (PCR) Market Outlook, By Diagnostic Center (2021-2030) ($MN)
  • Table 22 Global Polymerase Chain Reaction (PCR) Market Outlook, By Academia (2021-2030) ($MN)
  • Table 23 Global Polymerase Chain Reaction (PCR) Market Outlook, By Laboratories (2021-2030) ($MN)
  • Table 24 Global Polymerase Chain Reaction (PCR) Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 25 North America Polymerase Chain Reaction (PCR) Market Outlook, By Country (2021-2030) ($MN)
  • Table 26 North America Polymerase Chain Reaction (PCR) Market Outlook, By Product (2021-2030) ($MN)
  • Table 27 North America Polymerase Chain Reaction (PCR) Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 28 North America Polymerase Chain Reaction (PCR) Market Outlook, By Digital PCR Systems (2021-2030) ($MN)
  • Table 29 North America Polymerase Chain Reaction (PCR) Market Outlook, By Standard PCR Systems (2021-2030) ($MN)
  • Table 30 North America Polymerase Chain Reaction (PCR) Market Outlook, By Real-Time PCR Systems (2021-2030) ($MN)
  • Table 31 North America Polymerase Chain Reaction (PCR) Market Outlook, By Reagents (2021-2030) ($MN)
  • Table 32 North America Polymerase Chain Reaction (PCR) Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 33 North America Polymerase Chain Reaction (PCR) Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 34 North America Polymerase Chain Reaction (PCR) Market Outlook, By Application (2021-2030) ($MN)
  • Table 35 North America Polymerase Chain Reaction (PCR) Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 36 North America Polymerase Chain Reaction (PCR) Market Outlook, By Blood Testing (2021-2030) ($MN)
  • Table 37 North America Polymerase Chain Reaction (PCR) Market Outlook, By Pathogen Detection (2021-2030) ($MN)
  • Table 38 North America Polymerase Chain Reaction (PCR) Market Outlook, By Research (2021-2030) ($MN)
  • Table 39 North America Polymerase Chain Reaction (PCR) Market Outlook, By Forensic (2021-2030) ($MN)
  • Table 40 North America Polymerase Chain Reaction (PCR) Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 41 North America Polymerase Chain Reaction (PCR) Market Outlook, By End User (2021-2030) ($MN)
  • Table 42 North America Polymerase Chain Reaction (PCR) Market Outlook, By Pharmaceutical (2021-2030) ($MN)
  • Table 43 North America Polymerase Chain Reaction (PCR) Market Outlook, By Hospital (2021-2030) ($MN)
  • Table 44 North America Polymerase Chain Reaction (PCR) Market Outlook, By Clinical Research Organizations (2021-2030) ($MN)
  • Table 45 North America Polymerase Chain Reaction (PCR) Market Outlook, By Diagnostic Center (2021-2030) ($MN)
  • Table 46 North America Polymerase Chain Reaction (PCR) Market Outlook, By Academia (2021-2030) ($MN)
  • Table 47 North America Polymerase Chain Reaction (PCR) Market Outlook, By Laboratories (2021-2030) ($MN)
  • Table 48 North America Polymerase Chain Reaction (PCR) Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 49 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Country (2021-2030) ($MN)
  • Table 50 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Product (2021-2030) ($MN)
  • Table 51 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 52 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Digital PCR Systems (2021-2030) ($MN)
  • Table 53 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Standard PCR Systems (2021-2030) ($MN)
  • Table 54 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Real-Time PCR Systems (2021-2030) ($MN)
  • Table 55 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Reagents (2021-2030) ($MN)
  • Table 56 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 57 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 58 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Application (2021-2030) ($MN)
  • Table 59 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 60 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Blood Testing (2021-2030) ($MN)
  • Table 61 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Pathogen Detection (2021-2030) ($MN)
  • Table 62 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Research (2021-2030) ($MN)
  • Table 63 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Forensic (2021-2030) ($MN)
  • Table 64 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 65 Europe Polymerase Chain Reaction (PCR) Market Outlook, By End User (2021-2030) ($MN)
  • Table 66 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Pharmaceutical (2021-2030) ($MN)
  • Table 67 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Hospital (2021-2030) ($MN)
  • Table 68 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Clinical Research Organizations (2021-2030) ($MN)
  • Table 69 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Diagnostic Center (2021-2030) ($MN)
  • Table 70 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Academia (2021-2030) ($MN)
  • Table 71 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Laboratories (2021-2030) ($MN)
  • Table 72 Europe Polymerase Chain Reaction (PCR) Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 73 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Country (2021-2030) ($MN)
  • Table 74 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Product (2021-2030) ($MN)
  • Table 75 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 76 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Digital PCR Systems (2021-2030) ($MN)
  • Table 77 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Standard PCR Systems (2021-2030) ($MN)
  • Table 78 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Real-Time PCR Systems (2021-2030) ($MN)
  • Table 79 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Reagents (2021-2030) ($MN)
  • Table 80 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 81 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 82 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Application (2021-2030) ($MN)
  • Table 83 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 84 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Blood Testing (2021-2030) ($MN)
  • Table 85 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Pathogen Detection (2021-2030) ($MN)
  • Table 86 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Research (2021-2030) ($MN)
  • Table 87 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Forensic (2021-2030) ($MN)
  • Table 88 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 89 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By End User (2021-2030) ($MN)
  • Table 90 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Pharmaceutical (2021-2030) ($MN)
  • Table 91 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Hospital (2021-2030) ($MN)
  • Table 92 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Clinical Research Organizations (2021-2030) ($MN)
  • Table 93 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Diagnostic Center (2021-2030) ($MN)
  • Table 94 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Academia (2021-2030) ($MN)
  • Table 95 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Laboratories (2021-2030) ($MN)
  • Table 96 Asia Pacific Polymerase Chain Reaction (PCR) Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 97 South America Polymerase Chain Reaction (PCR) Market Outlook, By Country (2021-2030) ($MN)
  • Table 98 South America Polymerase Chain Reaction (PCR) Market Outlook, By Product (2021-2030) ($MN)
  • Table 99 South America Polymerase Chain Reaction (PCR) Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 100 South America Polymerase Chain Reaction (PCR) Market Outlook, By Digital PCR Systems (2021-2030) ($MN)
  • Table 101 South America Polymerase Chain Reaction (PCR) Market Outlook, By Standard PCR Systems (2021-2030) ($MN)
  • Table 102 South America Polymerase Chain Reaction (PCR) Market Outlook, By Real-Time PCR Systems (2021-2030) ($MN)
  • Table 103 South America Polymerase Chain Reaction (PCR) Market Outlook, By Reagents (2021-2030) ($MN)
  • Table 104 South America Polymerase Chain Reaction (PCR) Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 105 South America Polymerase Chain Reaction (PCR) Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 106 South America Polymerase Chain Reaction (PCR) Market Outlook, By Application (2021-2030) ($MN)
  • Table 107 South America Polymerase Chain Reaction (PCR) Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 108 South America Polymerase Chain Reaction (PCR) Market Outlook, By Blood Testing (2021-2030) ($MN)
  • Table 109 South America Polymerase Chain Reaction (PCR) Market Outlook, By Pathogen Detection (2021-2030) ($MN)
  • Table 110 South America Polymerase Chain Reaction (PCR) Market Outlook, By Research (2021-2030) ($MN)
  • Table 111 South America Polymerase Chain Reaction (PCR) Market Outlook, By Forensic (2021-2030) ($MN)
  • Table 112 South America Polymerase Chain Reaction (PCR) Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 113 South America Polymerase Chain Reaction (PCR) Market Outlook, By End User (2021-2030) ($MN)
  • Table 114 South America Polymerase Chain Reaction (PCR) Market Outlook, By Pharmaceutical (2021-2030) ($MN)
  • Table 115 South America Polymerase Chain Reaction (PCR) Market Outlook, By Hospital (2021-2030) ($MN)
  • Table 116 South America Polymerase Chain Reaction (PCR) Market Outlook, By Clinical Research Organizations (2021-2030) ($MN)
  • Table 117 South America Polymerase Chain Reaction (PCR) Market Outlook, By Diagnostic Center (2021-2030) ($MN)
  • Table 118 South America Polymerase Chain Reaction (PCR) Market Outlook, By Academia (2021-2030) ($MN)
  • Table 119 South America Polymerase Chain Reaction (PCR) Market Outlook, By Laboratories (2021-2030) ($MN)
  • Table 120 South America Polymerase Chain Reaction (PCR) Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 121 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Country (2021-2030) ($MN)
  • Table 122 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Product (2021-2030) ($MN)
  • Table 123 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 124 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Digital PCR Systems (2021-2030) ($MN)
  • Table 125 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Standard PCR Systems (2021-2030) ($MN)
  • Table 126 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Real-Time PCR Systems (2021-2030) ($MN)
  • Table 127 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Reagents (2021-2030) ($MN)
  • Table 128 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 129 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 130 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Application (2021-2030) ($MN)
  • Table 131 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 132 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Blood Testing (2021-2030) ($MN)
  • Table 133 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Pathogen Detection (2021-2030) ($MN)
  • Table 134 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Research (2021-2030) ($MN)
  • Table 135 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Forensic (2021-2030) ($MN)
  • Table 136 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 137 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By End User (2021-2030) ($MN)
  • Table 138 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Pharmaceutical (2021-2030) ($MN)
  • Table 139 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Hospital (2021-2030) ($MN)
  • Table 140 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Clinical Research Organizations (2021-2030) ($MN)
  • Table 141 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Diagnostic Center (2021-2030) ($MN)
  • Table 142 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Academia (2021-2030) ($MN)
  • Table 143 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Laboratories (2021-2030) ($MN)
  • Table 144 Middle East & Africa Polymerase Chain Reaction (PCR) Market Outlook, By Other End Users (2021-2030) ($MN)
目次
Product Code: SMRC24535

According to Stratistics MRC, the Global Polymerase Chain Reaction (PCR) Market is accounted for $8.9 billion in 2023 and is expected to reach $19.1 billion by 2030 growing at a CAGR of 11.5% during the forecast period. Polymerase Chain Reaction (PCR) is a molecular method for producing millions of copies of a particular DNA strand through in-vitro amplification. PCR is highly sensitive and can detect minute quantities of DNA. This is particularly advantageous in applications where the target DNA is present in low concentrations, such as in the early stages of certain diseases or when analyzing trace amounts of DNA in forensic samples.

According to Indian Council of Medical Research (ICMR), there will be a 12 percent rise in cancer cases in India by the 2027.

Market Dynamics:

Driver:

Rising demand for genetic testing

The rising demand for genetic testing has been a significant driver in the polymerase chain reaction (PCR) market. Genetic testing involves the analysis of an individual's DNA to identify genetic variations, mutations, and gene expression patterns. PCR plays a crucial role in this process by amplifying specific DNA sequences for further analysis. Additionally, genetic testing has gained popularity among individuals who are curious about their ancestry and want to explore their genetic heritage. Therefore, these advancements have expanded the applications of PCR in genetic testing, contributing to the growth of the PCR market.

Restraint:

High cost

The initial investment in PCR instruments, reagents, and consumables, coupled with the need for skilled personnel, contributes to the overall expense, especially for smaller diagnostic facilities and laboratories. The sophisticated nature of PCR equipment and the continuous requirement for quality control further add to the operational costs. Additionally, the expense of PCR tests may burden patients and healthcare systems, impacting the affordability and equitable distribution of cutting-edge diagnostic services. Therefore, high costs are a significant barrier to market expansion.

Opportunity:

Technological advancements

Real-time PCR allows for the detection and quantification of PCR amplification in real-time, providing immediate results during the amplification process. This real-time monitoring enables faster and more precise analysis, making it valuable in fields such as clinical diagnostics, genetic testing, and research. Furthermore, advancements in PCR instrument technology have resulted in more user-friendly and automated systems. Integrated thermal cyclers with advanced temperature control algorithms and intuitive software interfaces have made PCR more accessible to a broader range of users, including researchers, clinicians, and technicians. These advancements in technology are a significant factor in accelerating market demand.

Threat:

Complexity and technical expertise

A certain level of technical knowledge and training is required for the various steps involved in PCR techniques, which include primer design, reaction condition optimization, and data analysis. PCR protocols require careful design and selection of primers that specifically target the desired DNA regions. Designing primers with appropriate melting temperatures, avoiding secondary structures, and minimizing primer-dimer interactions can be challenging. The complexity and technical expertise required to perform polymerase chain reaction (PCR) act as restraints in the polymerase chain reaction (PCR) market.

COVID-19 Impact

The COVID-19 pandemic significantly impacted the polymerase chain reaction market growth. The growing demand in the clinical diagnostic market segment had a favourable effect on the PCR market. Healthcare professionals advised the population exhibiting COVID-19 symptoms to have a diagnostic test performed, and nearly all of these tests use RT-PCR since viral culture tests have not been recommended by the authorities. Most pharmaceutical and biotechnological companies were focusing on the research and development departments to identify new molecules or leads for the treatment of COVID-19.

The reagents segment is expected to be the largest during the forecast period

The reagents segment is estimated to hold the largest share. PCR reagents encompass a range of chemicals, including DNA polymerases, primers, nucleotides, and buffers, each playing a specific role in the reaction. DNA polymerases, such as Taq polymerase, catalyze the synthesis of complementary DNA strands, while primers provide the starting points for DNA amplification. Nucleotides serve as building blocks for the newly synthesized DNA strands, and buffers maintain the optimal pH conditions for enzymatic activity. The demand for high-quality and reliable reagents is paramount for the accuracy and efficiency of PCR reactions.

The diagnostic center segment is expected to have the highest CAGR during the forecast period

The diagnostic center segment is anticipated to have lucrative growth during the forecast period. PCR technology is extensively utilized in diagnostic centers for the detection of various diseases, including infectious agents, genetic disorders, and cancer. Diagnostic centers leverage PCR's high sensitivity and specificity to identify and quantify specific DNA or RNA sequences, aiding in the early and precise diagnosis of diseases. The versatility of PCR enables diagnostic centers to offer a wide range of tests, contributing to comprehensive patient care.

Region with largest share:

North America commanded the largest market share during the extrapolated period. The high frequency of diseases, the presence of important players in the region, the existence of favourable regulations, and a number of government initiatives pertaining to advancements in healthcare infrastructure all contribute to the growth of the regional market. An additional factor fueling the growth is growing patient awareness of the availability of contemporary products for successful diagnosis.

Region with highest CAGR:

Asia Pacific is expected to witness profitable growth over the projection period, owing to the rising incidence of infectious diseases, the growing recognition of personalized medicine, and the improvements made to the healthcare system. Asian countries are seeing an increase in research endeavours, specifically in the fields of genomics, oncology, and infectious disease investigations. This has led to the widespread use of PCR as a precise and efficient method of amplifying DNA. Moreover, the region's diverse population and genetic variations necessitate robust molecular diagnostics for personalized treatment strategies, further fueling the PCR market.

Key players in the market:

Some of the key players in the Polymerase Chain Reaction (PCR) Market include Danaher Corporation, Fluidigm Corporation, Agilent Technologies, Inc., Stilla Technologies, Abbott, Cytiva, Microsynth AG, Qiagen, JN Medsys, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd, Siemens, Johnson & Johnson Private Limited and Bruker.

Key Developments:

In August 2022, Abbott and weightwatchers partner to support people living with diabetes in attaining their health goals. Two industry leaders join forces to empower people living with diabetes by providing information and insights to improve weight loss, glucose control and overall health.

In June 2021, Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, announced a partnership with Seegene, Inc., a global leader in multiplex molecular diagnostics, for the clinical development and commercialization of infectious disease molecular diagnostic products.

Products Covered:

  • Instruments
  • Reagents
  • Consumables
  • Other Products

Applications Covered:

  • Oncology
  • Blood Testing
  • Pathogen Detection
  • Research
  • Forensic
  • Other Applications

End Users Covered:

  • Pharmaceutical
  • Hospital
  • Clinical Research Organizations
  • Diagnostic Center
  • Academia
  • Laboratories
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Polymerase Chain Reaction (PCR) Market, By Product

  • 5.1 Introduction
  • 5.2 Instruments
    • 5.2.1 Digital PCR Systems
    • 5.2.2 Standard PCR Systems
    • 5.2.3 Real-Time PCR Systems
  • 5.3 Reagents
  • 5.4 Consumables
  • 5.5 Other Products

6 Global Polymerase Chain Reaction (PCR) Market, By Application

  • 6.1 Introduction
  • 6.2 Oncology
  • 6.3 Blood Testing
  • 6.4 Pathogen Detection
  • 6.5 Research
  • 6.6 Forensic
  • 6.7 Other Applications

7 Global Polymerase Chain Reaction (PCR) Market, By End User

  • 7.1 Introduction
  • 7.2 Pharmaceutical
  • 7.3 Hospital
  • 7.4 Clinical Research Organizations
  • 7.5 Diagnostic Center
  • 7.6 Academia
  • 7.7 Laboratories
  • 7.8 Other End Users

8 Global Polymerase Chain Reaction (PCR) Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Danaher Corporation
  • 10.2 Fluidigm Corporation
  • 10.3 Agilent Technologies, Inc.
  • 10.4 Stilla Technologies
  • 10.5 Abbott
  • 10.6 Cytiva
  • 10.7 Microsynth AG
  • 10.8 Qiagen
  • 10.9 JN Medsys
  • 10.10 Bio-Rad Laboratories, Inc.
  • 10.11 Thermo Fisher Scientific, Inc.
  • 10.12 F. Hoffmann-La Roche Ltd
  • 10.13 Siemens
  • 10.14 Johnson & Johnson Private Limited
  • 10.15 Bruker